Back to Browse Journals » Medicolegal and Bioethics » Volume 2

REACH, animal testing, and the precautionary principle

Authors Menache A, Nastrucci C

Received 19 April 2012

Accepted for publication 11 May 2012

Published 6 August 2012 Volume 2012:2 Pages 13—29


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Video abstract presented by Andre Menache

Views: 512

Andre Menache,1 Candida Nastrucci2

1Antidote Europe, Perpignan, France; 2University of Rome, "Tor Vergata", Rome, Italy

Abstract: Relatively little is known about the toxicity of the many chemicals in existence today. This has prompted European Union regulatory authorities to launch a major chemicals testing program, known as Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). Although the driving force behind REACH is ostensibly based on the precautionary principle, in practice, the evidence suggests that it is oriented more toward risk assessment than precaution. In addition, the test methods used to assess chemical risk also raise questions about the efficacy of REACH in achieving its stated aims of protecting human health and the environment. These tests rely in large part on animal models. However, based on empirical evidence and on well-established principles of evolutionary biology and complex systems, the animal model fails as a predictive modality for humans. In turn, these concerns raise significant ethical and legal issues that must be addressed urgently. Immediate measures should include a major biomonitoring program to reliably assess the chemical burden in European Union citizens as a means of prioritizing the most dangerous substances present in the environment. Blood and urine biomarkers are useful tools with which to implement biomonitoring and to help guide public policy. An ecological paradigm, based on pollution prevention, rather than pollution control and risk assessment of individual chemicals, represents a superior strategy, to prevent global chemical pollution and toxicity risks to human health.

Keywords: precautionary principle, risk, chemicals, animal tests, biomonitoring

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Nanoscale TiO2 nanotubes govern the biological behavior of human glioma and osteosarcoma cells

Tian A, Qin XF, Wu A, Zhang H, Xu Q, Xing D, Yang H, Qiu B, Xue X, Zhang D, Dong C

International Journal of Nanomedicine 2015, 10:2423-2439

Published Date: 25 March 2015

Synthesis, pharmacokinetics, and biological use of lysine-modified single-walled carbon nanotubes [Erratum]

Mulvey JJ, Feinberg EN, Alidori S, McDevitt MR, Heller DA, Scheinberg DA

International Journal of Nanomedicine 2015, 10:595-596

Published Date: 14 January 2015

Magnetoledtherapy in the treatment of wounds after surgical procedures of the knee joint

Pasek J, Pasek T, Sieroń A

Therapeutics and Clinical Risk Management 2014, 10:717-720

Published Date: 2 September 2014

Development of novel cationic chitosan- and anionic alginate–coated poly(D,L-lactide-co-glycolide) nanoparticles for controlled release and light protection of resveratrol

Sanna V, Roggio AM, Siliani S, Piccinini M, Marceddu S, Mariani A, Sechi M

International Journal of Nanomedicine 2012, 7:5501-5516

Published Date: 17 October 2012

Decreased bacteria activity on Si3N4 surfaces compared with PEEK or titanium

Gorth DJ, Puckett S, Ercan B, Webster TJ, Rahaman M, Bal BS

International Journal of Nanomedicine 2012, 7:4829-4840

Published Date: 7 September 2012

Longitudinal course of deficient emotional self-regulation CBCL profile in youth with ADHD: prospective controlled study

Biederman J, Spencer TJ, Petty C, Hyder LL, O'Connor KB, Surman CBH, Faraone SV

Neuropsychiatric Disease and Treatment 2012, 8:267-276

Published Date: 25 June 2012

Application of supercritical antisolvent method in drug encapsulation: a review

Kalani M, Yunus R

International Journal of Nanomedicine 2011, 6:1429-1442

Published Date: 6 July 2011

Advances in the production of human monoclonal antibodies

Wang S

Antibody Technology Journal 2011, 1:1-4

Published Date: 29 June 2011